Huixiang Technology

Hangzhou Huixiang Pharmaceutical Technology Co., Ltd. (formerly Wenzhou Renji Pharmaceutical Co., Ltd.) was established in May 1998 and is primarily engaged in the sanitary products business, having gone through three stages of development. Currently, its offerings include X-ray machines, CT, surgical robots, lasers, arthroscopes, physical medicine rehabilitation, surface electromyography analysis and training systems (10-channel), hydraulic massage devices (dry waterbeds), intermittent pneumatic compression therapy devices, neural function reconstruction therapy systems, semiconductor laser therapy devices, intelligent rehabilitation training devices, balance function reconstruction therapy systems, electric standing beds, osteoporosis therapy devices, high-voltage potential therapy devices, 64-slice spiral CT, gamma knives, magnetic resonance imaging, color Doppler ultrasound systems, computed tomography therapy systems, hyperbaric oxygen chambers, and robotic surgical systems. The laboratory covers an area of more than 600 square meters and includes basic laboratories, an analysis and testing center, and pharmaceutical professional laboratories; it houses more than 1,500 sets of instruments and equipment, including over 30 large-scale precision instruments such as field emission scanning electron microscopes. The laboratory team is highly skilled, well-structured, and energetic, forming a new system integrating talent cultivation, scientific research, and social services. The laboratory undertakes experimental tasks for students majoring in pharmacy, pharmaceutical engineering, and related fields. Biotechnology, technology development, technology consulting, technology transfer, and technical services; pharmaceutical-related research topics, scientific research achievements, research funds, patent applications, and registration submissions; polishing and revision of pharmaceutical project evaluations, research project approvals, feasibility reports, project applications, business plans, project proposals, investment plans, and benefit evaluation reports; conducting pharmaceutical academic exchanges, pharmaceutical education, and application and evaluation of medical science and technology projects, etc.; after 22 years of development and growth, multiple medical and pharmaceutical project reports and project bids have passed the review of science and technology institutions at the provincial, municipal, and county levels; currently, the company has 16 senior registered consulting engineers, 15 registered appraisers, 27 senior engineers, 6 certified public accountants, 4 cost engineers, and 3 registered senior project managers; it is composed of professionals including intermediate cost engineers, accountants, and cost engineers, with document preparation expertise covering fields such as pharmaceuticals and bioengineering.